排序方式: 共有25条查询结果,搜索用时 15 毫秒
1.
In order to examine the effect of growth hormone on urinary pyridinoline excretion, 32 patients with complete or partial growth hormone deficiency had their urinary pyridinoline excretion measured while receiving growth hormone and for 14 days after it was discontinued. There was a significant positive correlation between increases in growth velocities during the first year of growth hormone administration compared to before it, and the ratio of the urinary pyridinoline excretion levels while receiving growth hormone to those after discontinuation. Therefore, urinary pyridinoline excretion rapidly decreased in patients with growth hormone deficiency when the administration of growth hormone was stopped. Exogenous growth hormone appears to stimulate bone resorption in these patients. 相似文献
2.
SHU TAKABATAKE M.D. KENSHI HAYASHI M.D. CHIAKI NAKANISHI M.D. HIROYUKI HAO M.D. KENJI SAKATA M.D. MASA‐AKI KAWASHIRI M.D. TAKEHISA MATSUDA Ph.D. MASAKAZU YAMAGISHI M.D. 《Journal of interventional cardiology》2014,27(1):63-72
Objectives
We evaluated the in vivo performance of a newly devised vascular endothelial growth factor (VEGF)‐bound stent in a porcine coronary model.Background
An anti‐CD34 antibody‐bound stent, which captures endothelial progenitor cells (EPCs) to accelerate tissue formation, did not reduce intimal hyperplasia. By targeting the VEGF receptor, which is expressed on endothelial‐lineage cells, we developed VEGF‐bound stents that may enable selective capture of EPCs followed by rapid endothelialization.Methods
Metallic stents were first coated with poly‐(ethylene‐co‐vinyl alcohol), and then chemically bound with either VEGF or anti‐CD34 antibody. These stents were placed in porcine coronary arteries for up to 14 days. Stent surface was evaluated by immunohistochemistry and by scanning electron microscope (SEM).Results
After 2‐day stenting with VEGF‐bound stents, small populations of KDR (VEGF receptor‐2)‐positive cells adhered to the stent struts. After 7‐ and 14‐day stenting, struts were fully covered with newly regenerated tissue. SEM images showed that the uniform tissue formed on struts was morphologically similar to native endothelium and was continuously connected with adjacent native endothelium. On the other hand, for the anti‐CD34 antibody‐bound stents, stent struts were rapidly covered by newly generated tissue that consisted of multicellular aggregates.Conclusions
Compared with anti‐CD34 antibody‐bound stents, VEGF‐bound stents provide highly selective capture of EPCs, followed by rapid formation of intact endothelium tissue at an early period of stenting. These results suggest that VEGF‐bound stents could represent a promising therapeutic option for cardiovascular stenting, although further long‐term follow‐up experiment with double‐blinded fashion is needed prior to clinical application. (J Interven Cardiol 2014;27:63–72)3.
OCHS HERMANN R.; GREENBLATT DAVID J; LAUVEN PETER M.; STOECKEL HORST; ROMMELSHEIM KUNO 《British journal of anaesthesia》1982,54(8):849-852
The pharmacokineucs of high-dose i.v diazepam were studied intwo patients in an intensive care unit. The first patient receivedup to 240 mg of diazepaM.Daily for 21 days while the secondreceived 60 mg daily for 30 days Plasma concentrations of diazepamand its major metabolite, desmethyldiazepam, were very largebut, despite severe underlying disease and simultaneous administrationof several other drugs, the half-lives of diazepam and desmethyldiazepamwashout were consistent with those found in healthy persons.Washout half-lives in the first patient were, if anything, shorterthan expected, possibly caused by simultaneous administrationof phenobarbnone. Thus the kinetics of diazepam are apparentlynot altered by administration of large doses 相似文献
4.
KENSHI UEMURA M.D. HIDEKAZU KONDO M.D. Ph.D. YUMI ISHII M.D. MAMI KOBUKATA M.D. MIHO HARAGUCHI M.D. TAKAAKI IMAMURA M.D. TOYOKAZU OTSUBO M.D. YUKI IKEBE‐EBATA M.D. ICHITARO ABE M.D. REIKA AYABE M.D. SHOTARO SAITO M.D. Ph.D. KOHEI AOKI M.D. YASUKO NAGANO‐TORIGOE M.D. Ph.D. HIDEFUMI AKIOKA M.D. TETSUJI SHINOHARA M.D. Ph.D. YASUSHI TESHIMA M.D. Ph.D. TAKAYUKI MASAKI M.D. Ph.D. KUNIO YUFU M.D. Ph.D. MIKIKO NAKAGAWA M.D. Ph.D. NAOHIKO TAKAHASHI M.D. Ph.D. 《Journal of cardiovascular electrophysiology》2016,27(8):981-989
5.
YOHEI SOTOMI M.D. TAKAYUKI KIKKAWA KOICHI INOUE M.D. Ph.D. KOJI TANAKA M.D. YUKO TOYOSHIMA M.D. TAKAFUMI OKA M.D. Ph.D. NOBUAKI TANAKA M.D. YOICHI NOZATO M.D. YOSHIYUKI ORIHARA M.D. KATSUOMI IWAKURA M.D. Ph.D. YASUSHI SAKATA M.D. Ph.D. KENSHI FUJII M.D. Ph.D. 《Journal of cardiovascular electrophysiology》2014,25(9):941-947
6.
YOSHIYUKI MORIKAWA YASUO OHASHI KENSUKE HARADA TOSHIO ASAI SUMIO OKAWA MASAMI NAGASHIMA TOSHIYUKI KATOH KUNIZO BABA KENSHI FURUSHO MASAHIKO OKUNI MITSURU OSANO 《Pediatrics international》1994,36(4):347-354
We studied the effect of intravenous, polyethyleneglycol-treated, human immunoglobulin, administered at 200 mg/kg per day (group A: n = 147; male 86, female 61; age < 1 year, 50) or 400 mg/kg per day (group B: n = 152; male 87, female 65; age < l year, 52) for five consecutive days and compared it with freeze-dried, sulfonated human immunoglobulin [group C: n = 152; male 87, female 65; age < 1 year, 51), administered at 200 mg/kg per day for five consecutive days, on the prevention of coronary artery abnormalities in Kawasaki disease. Echocardiograms were interpreted blindly and independently. Proportions of 87.1%, 95.4%, and 82.3% in groups A, B, and C, respectively, had no coronary artery abnormalities. The confidence limits of difference between the proportions of groups A and C, groups B and C, and groups B and A were −4.4% and 10.4%, 7.8% and 15.9%, and 4.0% and 10.8%, respectively. Duration of fever and serum immunoglobulin G (IgG) levels were correlated with the prevalence of coronary artery abnormalities. We concluded that intravenous, polyethyleneglycol-treated, human immunoglobulin and freeze-dried, sulfonated human immunoglobulin had clinically equivalent effects on coronary artery abnormalities, and that five daily doses of 400 mg/kg of intravenous, polyethyleneglycol-treated, human immunoglobulin is more effective than that of 200 mg/kg gamma globulin. 相似文献
7.
KUNO S 《Kekkaku : [Tuberculosis]》1958,33(7):487-92; English abstract 519-20
8.
HIDEO KITA MOTOHARU OHI KAZUO CHIN TETSUO NOGUCHI NAOKI OTSUKA TOMOMASA TSUBOI HIROSHI ITOH KAZUWA NAKAO KENSHI KUNO 《Journal of sleep research》1998,7(3):199-207
The nocturnal secretion profile of the newly identified natriuretic peptide (NP), brain natriuretic peptide (BNP), was studied in 14 patients with obstructive sleep apnoea syndrome (OSAS) (apnoea hypopnoea index: 60.5±3.4, mean±SE) during two separate nights before and during nasal continuous positive airway pressure (NCPAP) therapy. Plasma levels of NPs (atrial natriuretic peptides; ANP and BNP) were measured at 2-h intervals during sleep. Simultaneously, blood pressure was measured by a non-invasive method (Finapres®, Ohmeda, Englewood, CO, USA) and urine was collected for determing volume and catecholamine levels. Urinary and serum sodium concentration were determined before and after the study. Eight non-snoring subjects were also studied for the investigation of normal nocturnal profiles of BNP levels. To understand the discrete secretion profiles of the two NPs during sleep, blood was sampled from an additional seven patients every 5 min over a 30-min period around 00.00 and 04.00 hours before NCPAP. In patients with OSAS, plasma BNP levels increased from the beginning of sleep (22:00 h) to the morning (06:00 h) before NCPAP therapy (P< 0.01, anova ). Baseline BNP levels were not significantly correlated with patient's clinical and poly- somnographic parameters. However, in the latter half of the sleep period (02:00–06:00 h), increases in BNP levels during the night before NCPAP therapy were significantly correlated with blood pressure elevations (systolic: r=0.784 P< 0.01, diastolic: r=0.587 P< 0.01) and with apnoea duration (r=0.582 P< 0.01). In normal subjects BP and BNP levels were not changed significantly during sleep. Plasma BNP levels were well correlated with concomitant ANP levels (P< 0.001). NCPAP therapy reduced ANP and BNP levels during sleep and in the morning (P< 0.01). Plasma levels of BNP at 5 min intervals before NCPAP therapy revealed few variations. On the other hand, ANP levels fluctuated over the 30-min period. Changes in BNP levels during sleep in the patients with OSAS may be related to blood pressure variations, but may be too small to play a significant physiological role in regulating diuresis in OSAS. Further work is required to determine the precise role of dual natriuretic system in cardiovascular load and natriuresis in OSAS. 相似文献
9.
The present study aimed to evaluate the absorption of D-xylose, a passively absorbed five-carbon monosaccharide, from the large intestine compared with the small intestine, in order to explore the absorption potential of the large intestine. D-Xylose absorption was evaluated in the intestinal loop and everted sacs in rats and comparisons were made between small intestine (mid-gut) and large intestine (colon). The absorption of D-xylose was smaller, by an order of magnitude or more, after administration into the loop of large intestine than after administration into that of small intestine, based on appearance in plasma and disappearance from the intestinal loop. D-Xylose absorption was practically insignificant (nominal 4.9%) in 60 min in the large intestine, whereas it was moderate (57.0%) in the small intestine. Consistently, the uptake of D-xylose in everted sacs was about 20 times larger in the small intestine than in the large intestine. Thus the passive membrane permeability of D-xylose was demonstrated to be negligible in the large intestine, even though the small intestine was fairly permeable. This result helps rationalize kinetic modelling strategies assuming the small intestine as the sole absorption site for gastrointestinal absorption in-vivo. It also suggests that hydrophilic drugs with molecular size similar to or larger than D-xylose may not be good candidates for colonic drug delivery by controlled release. 相似文献
10.
TADASHI SATO TATEO KUNO KATSUYA TASHIRO ICHIRO FUJITA SUMIO MIYAZAKI 《Pediatrics international》1998,40(1):93-95
A 10-year-old Japanese girl developed acute renal failure following a 100-meter dash during physical training at school. After the run, she experienced intense pain in the loins with nausea and vomiting lasting more than 12 h. On the following morning, she was found to have mild proteinuria and acute renal failure (ARF). Serum creatinine and blood urea nitrogen were elevated, but the serum uric acid level was normal (3.1 mg/dL). With recovery of renal function over the ensuing days, hypouricemia (0.6 mg/dL) became evident in the patient. Although the pathophysiological association between renal hypouricemia and ARF is not known, oxygen free radicals have been implicated in the pathogenesis for ischemic-reperfusion ARF. Superoxide production by neutrophils stimulated by N-formyl methionine leucyl-phenylalanine was normal in the patient both before and following exercise. Pyrazinamide and probenecid tests were undertaken on both the patient and her parents, who had borderline hypouricemia, to determine their renal tubular handling of uric acid. Results showed that the patient and her mother had a subtotal reabsorption defect, while the father had defective postsecretory uric acid reabsorption. 相似文献